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1 INTRODUCTION: CITATIONS AND RETRACTIONS  
To stand on the shoulder of giants is a common phrase, used to showcase the ideal of 
using other peoples’ research to further your own. Citations are a way of showing whose giant 
shoulders you have been standing on in order to see further into the world of science. 
This is the ideal for citations – the furthering of scientific ideas by showing not only were you 
want to go, but also where you came from. Sometimes, however, the giant shoulders you 
were standing on, is nothing but a pillar of lies. The self-correcting measure of science comes 
in the form of retractions. When an article has been found erroneous, be it from a simple 
mistake or more malignant reasons such as fraud and misconduct, said article should be 
retracted. The whole point of this practice is so that others in the future will not rely upon 
wrongful work in their research. However sometimes this is exactly what happens.  
In 2006 the Norwegian scientist, Doctor Jon Sudbø, considered to be a prodigy in his 
field, was exposed for committing research fraud. Sudbø was working hard on devising a 
method to identify markers of oral cancer. His breakthrough came when he made a discovery 
with the potential of diagnosing oral cancer at a much earlier stage than what was known 
before. Sudbø gained a lot of attention when he claimed that common painkillers could help 
prevent oral cancer. Yet they could also be dangerous since they would increase the risk of 
heart disease. The only problem with his discoveries was that they were simply not true. 
When people began looking into Sudbø’s articles it became clear that his research were 
largely based upon data which Sudbø had made up. He had gone so far as to create fictional 
patients with falsified names, social security numbers, and medical histories. When the 
discovery was made most of his articles were retracted. Thus pushing the giant that is Sudbø’s 
work down, making his shoulders unable to bear a load. However more than one fellow 
scientist have managed to find perch on the shoulders even after the articles were retracted. 
Ten years after the scandal Sudbø’s retracted articles are still cited.  
Jan Erik Frantsvåg, who works as Open Access advisor and researcher at the 
University of Tromsø – The Arctic University of Norway (UiT), was the one who made me 
aware of this, and it was his idea for me to take a closer look at the citing of retracted articles, 
with the case of the Sudbø-fraud as a backdrop. Citation counting, inspired by Eugene 





value of citation counting and its connection to the impact factor is heavily debated today. It 
would seem that a high number of citations are the same as, if not quality, at least impact. 
This puts pressure on scientists perpetuating the idea that you have to publish or perish. Some 
people have used this pressure as justification for their misconduct. Sudbø himself claimed 
that: “he lost his critical thinking in his strive for academic recognition” (Jakobsen, 
17.01.2014)  
It is all about getting your research out to the public. The pressure to publish is 
evident, seeing as everything from recognition, to tenure, and funding can depend upon it. 
One way to achieve more citations seems to be not only to publish something groundbreaking 
or controversial, but also to publish in a journal with a high impact factor. However being 
published in a high ranking journal does not necessarily equate to quality. In fact as the 
impact factor goes up, so does the retraction rate. (Ferric C. Fang & Casadevall, 2011) If the 
idea of retractions is to remove it as part of the scientific body, the question must be asked: 
why are retracted articles cited? 
 
1.1 WHAT WE KNOW SO FAR 
In order to better understand the citing of retracted articles I began by conducting a 
search of Google Scholar and Web of Science to find articles about retraction. This was to 
better understand the current state of retracted articles, and how they are cited. Before I 
started working with the subject I knew next to nothing about it. I guess in my naïve mind the 
idea of retractions had not occurred to me. It is so easy to think that scientific articles that are 
published are well-researched and without errors. However this would imply that every 
researcher and scientist are infallible people with a great sense of ethics and morals. Yet some 
of them cheat, lie and falsify data, seemingly without any form of moral quandary. When this 
type of fraud is discovered ideally their articles and scientific findings are retracted. Another 
reason for retraction can be simple errors and mistakes. Scientist, like the rest of us, are not 
infallible, they make honest mistakes too. Mistakes which can lead to retractions. In fact 
retractions are not unheard of in scientific publishing, but perhaps my naiveté stems from the 
fact that you do not hear about it that much. Others have written about the citing of retracted 





factors seems to be the agreement that not nearly as many articles that should be retracted are, 
and even if the retraction rate has increased tenfold in the past years (F. C. Fang, Steen, & 
Casadevall, 2012), the retraction number should be higher. This might not be so unreasonable 
since only 1 out of every 10 000 articles that are published are retracted (van der Vet & 
Nijveen, 2016). Another common thread is the agreement that retractions are a difficult thing 
to handle. Specially the citing of retracted articles, unless you know that a specific article is 
retracted, there is no easy way of finding it out. Many calls for a tool or program that can 
trace retractions, thus you avoid the citing of them. The emphasis on following the COPE-
guidelines in order to make people aware of retractions is also an area of import. These are 
subject areas I will look at closer as I explore the citations of retracted articles. I will use 
Sudbø’s retracted articles to gain an understanding of how people cite retracted article. Areas 
of import include citation indexing, and also the citers’ motives. The hope is to better 
understand the process of citing, why we cite, and why citations have become so important in 
the recent years through the emphasis of the impact factor. By gaining insight in these areas I 
hope to come a step closer into understanding not only how, and why we cite, but mainly why 
retracted articles are cited. 
 
1.2 THE LAYOUT OF THE PAPER 
I will begin by doing a literary review of retractions, and the citations of retracted 
articles in chapter two. Here I will also define citation indexes and how the importance of 
citations counting have become more prominent in the last years as more weight is put on the 
impact factor. In order to understand why Sudbø is cited I will also define different motives 
for citing in chapter two. The context of this examination is the case of Jon Sudbø, therefore I 
will outline his research career and eventual downfall in chapter four. I will do this to show 
the extent of his misconduct to show the reason for why his articles were retracted. As part of 
the examination of Sudbø I will do a citation count of two of Sudbø’s retracted articles. In 
conclusion I will discuss my findings of the citation count and try to determine why and how 






2 RETRACTED ARTICLES AND CITATION COUNTING 
The retraction of articles are not limited to one scholarly discipline, they occur in all 
fields and all affiliation countries (Grieneisen & Zhang, 2012). Yet the extent of published 
articles are not necessarily that big if you compare it to the overall amount of published 
articles. Paul E. van der Vet and Harm Nijveen estimate that about one in 10 000 published 
articles are retracted. There is still a worry that continued citing of the articles that are 
retracted could propagate the retracted results further (van der Vet & Nijveen, 2016). Svend 
Bruhns write about retractions in his book Citationsindexering, and how research articles 
containing errors are not always retracted. Sometimes because the errors of an article is not 
confirmed, and sometimes an article is not officially retracted even though it contains errors 
(Bruhns, 2010, p. 353). Every so often articles 
that are officially retracted are cited Sometimes 
as if a retraction notice have not been issued at 
all (Fulton et al., 2015).  Scientific journals 
which have published articles that are going to 
be retracted, should publish a notion letting 
people know about the retraction. Databases who 
catalogue scientific articles and have registered 
the original article should also take action. Since 
retracted articles are no longer part of the body 
of science, it is important to make the retractions 
known in order to prevent the spreading of retracted results (van der Vet & Nijveen, 2016). 
One way to do this is to follow the COPE-guidelines for retraction (COPE, 2009), if they are 
a member of COPE, which the journals with the highest impact factor generally are. This is to 
make sure that as many people as possible know about the retraction, to prevent future 
citations of the retracted article. When Balhara and Mishra checked retracted articles on 
mental disorder and the effect of the COPE guidelines on retraction, they discovered that “a 
significantly higher proportion of articles cited at least once post-retraction were without a 
freely accessible retraction notice” One key issue was that the retraction notice was freely 
accessible, since significantly fewer retracted articles with the retraction notice freely 
“Even after retraction notice 
has been issued, authors and 
peer reviewers still, presumably, 
unknowingly, cite the article as 
though no retraction notice had 
been issued.” 






accessible were cited (Balhara & Mishra, 2014). When doing a study to determine reasons for 
retraction, Steen discovered that 31.8% of the retracted articles in the study were not in 
compliance with the COPE-guidelines, since they did not have any mention of the retraction 
notice in the PDF. This is usually done with some kind of watermark, which these did not 
have (Steen, 2011). Another issue is that not all authors use a digital copy of an article when 
citing. Sometimes a researcher has filed away a hard-copy of an article for “future research”. 
If they are diligent and try to check to see if an article has been retracted, they do not have a 
guaranty that a simple search in some database will show that. van der Vet and Nijveen found 
that in their experience, none of the popular search engines like Google Scholar, Scopus or 
Web of Science added a warning to a retracted paper in their list of search results. Others have 
found that they did, but that the adding of a retraction warning was not done consistently (van 
der Vet & Nijveen, 2016). In 2010 Steen found that retractions were mainly due to error. Out 
of 742 English language research papers retracted from the PubMed database between 2000 
and 2010, 73.5% of the retractions were due to error, or an undisclosed reason. 26.6% of 
retractions were due to fraud. Yet he noted that the incidences of research fraud was 
increasing (Steen, 2011). In 2012 he and Ferric C Fang, and Arturo Casadevall came to the 
same conclusion: that fraud was increasing. They found that scientific misconduct accounts 
for the majority of retracted scientific publications (F. C. Fang et al., 2012). They conducted a 
review of all retraced biomedical and life-science research articles indexed in PubMed in May 
2012 and discovered that 21.3% of retractions were due to error. 43.4% were due to fraud, 
14.2% were duplicate publications and 9.8% was plagiarism. Miscellaneous reasons or 
unknown reasons accounted for the rest. Fang et al. blames incomplete, uninformative, or 
misleading retraction announcements for a previous underestimation of the role fraud plays in 
retractions. Since 1975 the percentage of articles retracted for research fraud have increased 
nearly tenfold. It seemed as if a small number of authors were responsible for multiple 
retractions, where authors who had more than ten retractions, almost always where retracted 
because of fraud. In terms of the citation of retracted articles they found that some retracted 
articles continue to be cited as valid, whilst other experience a rapid and sustained decline in 
citations after retraction.  They noted that there were articles shrouded in considerable doubt, 





number of articles who are retracted because of fraud, could therefore potentially be higher.  
The rate could also be higher, since many journals does not include the reason for retraction, 
therefore it is difficult to determine if the retraction is due to misconduct. (F. C. Fang et al., 
2012) 
They also point out the correlation 
between a high journal impact 
factor and a high retraction rate. A 
point which Fang and Casadevall 
revisits in the editorial “Retracted 
Science and the Retraction Index”. 
If you look at all of the scientific 
articles that are published today, 
retractions are a relatively rare 
occurrence. When Fang and 
Casadevall looked at the over 
28,000 articles over the course of 
40 years, Infection and Immunity had issued only 15 retractions. Of these retractions eight 
were retracted because of misconduct, and six were retracted by the authors because of errors, 
while the remaining articles were retracted due to extensive plagiarism. Even though they 
point out that retractions are a rare occurrence, they also note that manuscript retractions seem 
to be happening more often these days. This could be due to an increase in misconduct, but it 
could also be the result of “increased detection due to enhanced vigilance” (Ferric C. Fang & 
Casadevall, 2011, p. 3855). Fang and Casadevall also point out that: “most scientist feel that 
research misconduct is uncommon”, yet a meta-analysis of survey data found that 2% of 
scientist reported they have committed serious research misconduct at least once, and one-
third admitted that they had engaged in questionable research practices. Again prompting 
Fang et al. to question if the retractions we know of today, are only scratching the surface of 
the subject. If an author or an article is suspected of misconduct it is not the journals job to 
investigate, the primary responsibility of investigation is on the institution of the author. 
                                                 
1 (Ferric C. Fang & Casadevall, 2011, p. 3856) 
 
Figure 1 





However an editor needs to stay vigilant and report if any suspicion of misconduct should 
arise. When an institution has conducted their investigation it is up to the editor and the 
journal to react accordingly. Both publishers and authors can request a retraction, and a 
retracted article should report who has issued the retraction, why, and it should be clear that 
an article is retracted by following the COPE-guidelines. To investigate if there was a 
correlation between retraction frequency and the journal impact factor, they searched PubMed 
for retracted articles among 17 journals with an impact factor from 2.00 to 53.484. They 
devised a retraction index for each journal by taking the number of retractions from 2001 to 
2010, multiplied by 1000, and divided by the number of published articles with abstracts. 
What they found was that there was a clear correlation between the journal retraction index 
and the journal impact factor. A reason for this correlation might be the economic and social 
benefits associated with publishing in high impact journals. Today publication in high impact 
journals can lead to improved job opportunities, increased likelihood of receiving grants, peer 
recognition, honorific rewards, even if it is a widespread notion that the impact factor is a 
flawed measurement of scientific quality and significance. This means that the benefits of 
publishing in high impact journals can make scientist more prone to commit misconduct. 
Another reason may be the demand and desire from the high impact journals for clear and 
definite results, which may encourage authors to manipulate their data in order to present a 
clear-cut result, when the reality of everyday science may not yield such straightforward 
conclusions. The other side of the coin is 
of course the fact that higher impact 
journals may have increased visibility so 
they may be under greater scrutiny, so 
that misconduct is easier to spot (Ferric 
C. Fang & Casadevall, 2011). Murat 
Cokol et al. also mentions the higher 
level of scrutiny that high impact 
journals go through, and questions if 
more articles would be retracted if they underwent the same scrutiny (Cokol, Iossifov, 
Rodriguez-Esteban, & Rzhetsky, 2007). Claiming, like so many others that not all articles 
that should be retracted are retracted (Budd, Sievert, Schultz, & Scoville, 1999). 
“…this preliminary investigation suggests 
that the probability that an article published 
in a higher-impact journal will be retracted 
is higher than that for an article published in 
a lower impact journal.” 






Whatever the reason for the correlation, Fang et al. suggest further studies of the subject, also 
claiming that the correlation between impact factor and retraction rate, is yet another reason 
against using bibliometrics as a measure for scientific performance. In conclusion Fang and 
Casadevall are troubled by the increase in retracted scientific articles. Erroneous and 
fraudulent research has major ramifications for scientist who are lead astray by falsified 
results, an unfair distribution of scientific resources, and the potential harm it could cause due 
to inappropriate medical treatments of patients. Not to mention the chink in the armour of the 
public confidence in science. The scientific process relies on trust, and retractions and the 
misconduct of scientist erodes away at that trust. Yet, the infallible scientist does not exist, 
and retractions are science way of correcting mistakes (Ferric C. Fang & Casadevall, 2011). 
Even so, this self-correcting measure does not always work. In 2015 Helmar Borneman-
Cimenti, Istvan S. Szilagyi and Andreas Sandner-Kielsing released their article “Perpetuation 
of Retracted Publications Using the Example of the Scott S. Reuben Case: Incidences, 
Reasons and Possible Improvements”, where they investigated the continued citations of 
Scott S. Reuben, after his work had been retracted due to fraud. They differentiated between 
citations that noted the retractions and the ones that did not. Reuben’s work was retracted in 
2009, but have been cited 274 times in a five year period after retraction. Bornemann-Cimenti 
et al. found that in only 25.8% of the citing articles was it made clear that Reuben’s work had 
been retracted. There was a sharp decline in the number of citations in 25% of the journals, as 
well as a decline in citations within Reuben’s field after the retractions in 2009. Yet 
Bornemann-Cimenti et al. found that even five years after retraction, nearly half of Reuben’s 
articles are still cited, with only one quarter of the citations mentioning the retraction. 
Retracted articles should no longer be considered part of the current literature, therefore the 
continued citations of retracted articles for the people who build upon, since it can lead 
scientist astray and result in unwarranted recommendations. One reason for the citation of 
retracted articles Bornemann-Ciment et al. attribute to the fact that people may be unaware of 
the retractions, especially for authors outside Reuben’s field of perioperative pain 
management. Their data showed that in 2009 72% of citations came from authors with an 
anaesthesia or pain association, whereas in the years after the percentage varied between 36% 





citations after retraction stems from not being aware of the retraction. However in their study 
they found that only one letter, or 4% of the total number of articles included, was not 
labelled as retracted. Yet the availability of multiple online versions of the same article, can 
be the cause of citations, since not all of these make a note of the retraction, leaving readers 
unaware of the papers status. Another reason for the citation of retracted articles can be the 
same as van der Vet and Nijveen bring up (van der Vet & Nijveen, 2016). That some authors 
collect and file articles in order to quote them later, thus not being aware of changes, or 
retractions that might have happened after they originally found the literature. Finally 
Bornemann-Cimenti et al. bring up the reviewing process, and the expectation put upon them 
to catch mistakes, such as the citation of a retracted article. However they point out that the 
reviewers and editors may be experienced researcher, yet they are not immune to making the 
same mistakes, or in this case, not catching the same mistakes that authors were unable to 
catch. Automated software that help in the 
research and reviewing process might be a 
solution to this, by checking for note of 
retraction, but as Bornemann-Cimenti et al. 
notes, such tools are not yet available. Until 
such tool are available the only solution is to 
make people more aware of the situation and 
the problem of continued citing of retracted 
articles (Bornemann-Cimenti et al., 2015). Van der Vet and Nijveen also believe that 
computer programs may be of help in lessening the citing of retracted articles. This requires 
publishers to structure the retraction status in such a way that it will be readable to a computer 
programme. Before that time comes, vigilance is required, and one must keep tracking 
retractions. Blogs such as Retraction Watch aids in this tracking, since automated methods are 
not yet available (van der Vet & Nijveen, 2016). 
  
“In conclusion, the analysis of Reuben’s 
publications clearly shows that retracted 
articles are still cited 5 years after.” 






2.1 THE COMMITTEE ON PUBLICATION ETHICS (COPE) 
When people write about retractions one of the most common thing is for them to 
emphasize the importance of letting people know about the retraction. One ideal method is to 
follow the COPE and The International Medical Journal Editor guidelines. 
In 1997 a small group of medical journal editors in the UK established The Committee 
on Publication Ethics (COPE). The goal was to provide advice to editors and publishers on all 
aspects of publication ethics. One particular important feature was to provide a framework on 
how to handle research and publication misconduct. COPE has over 10 000 members’ 
worldwide, members who are all expected to follow the Code of Conduct for Journal Editors. 
The goal of COPE is to promote transparency in scholarly publishing. One of the services 
they provide are guidelines to journals editors on how to handle retractions (COPE, 2016).  
2.1.1 RETRACTION GUIDELINES 
The COPE retraction guidelines instruct the journal editors in when and how to retract. 
The purpose of retraction is to have a mechanism for correcting the literature and alerting 
readers about publications with such grave errors that they are not reliable, and to avoid the 
duplication of data. The main goal of retractions is to correct the literature in order to ensure 
its integrity. According to the guidelines journals should consider retraction of a publication if 
they have evidence of errors either from misconduct, like in the case of Sudbø, or with data 
fabrication, or honest mistakes such as a miscalculation or experimental error. A retraction 
should also happen if the findings have been published elsewhere without proper cross-
referencing, permission or justification, or due to plagiarism or unethical research. Journal 
editors can also issue expression of concern and corrections. When something has been 
retracted the journal must provide proper notification of this. According to the guidelines this 
means that a notice of retraction should:  
 be linked to the retracted article wherever possible (i.e. in all electronic 
versions) 
 clearly identify the retracted article (e.g. by including the title and authors in 





 be clearly identified as a retraction (i.e. distinct from other types of correction 
or comment) 
 be published promptly to minimize harmful effects from misleading 
publications 
 be freely available to all readers (i.e. not behind access barriers or available 
only to subscribers) 
 state who is retracting the article 
 state the reason(s) for retraction (to distinguish misconduct from honest error) 
 avoid statements that are potentially defamatory or libellous (COPE, 2009) 
 
2.2 CITATION COUNTING 
Citations are a mandatory part of scientific publishing. It provides us with a link 
between documents. The scientist does his research and build upon what was there before 
him, using already established techniques and concepts to further the progress of his field. 
This dependency of what came before is acknowledged through bibliographic references as “a 
silent code of honours” (Bellis, 2009, p. xvii) Doctor Eugene Garfield is considered a pioneer 
in the field of bibliometrics, the statistical analysis of a written publication, such as an article 
or a book. Citation analysis is an integral part of bibliometrics. Citation analysis in its 
simplest form consist of counting how many times something or someone have been cited by 
others. These citation counts can be used to demonstrate the position of an author in his field. 
It can be used to see who is citing who, and thus determine if there are any links between 
different documents. For instance if one group of authors are citing each other multiple times, 
one could assume that there is a strong link between the citing documents and the cited ones.  
Citation analysis really blossomed in the 1960s mostly due to Garfield and his citation 
indexes (Bruhns, 2010, pp. 17-19). The ideal for Garfield, which he proposed in 1955, was a 
bibliographic system that could eliminate the uncritical citation of wrongful data, be it 
fraudulent, incomplete or obsolete. To do this, Garfield felt that the criticism of earlier papers 
must be made available through citation indexing (Garfield, 2006a, p. 1123). The hope was to 
give researchers a way to evaluate the impact of their work, speed up the research process, 





the foundations for the Institute for Scientific Information (ISI), now known as Thomson ISI, 
a dominant force in terms of citation indexing. Scientific indexes at that time were discipline-
oriented, which meant that researchers struggled to find the information relevant to their 
work, since relevant papers from other disciplines were ignored when researching a scientific 
area by only using subject or keywords. Searching through published scientific papers for 
relevant information was therefore a labour-intensive process, which seldom yielded the 
desired results (Yancey, 2005). The Science Citation Index was first available in print form in 
1964, and two years later the Science Citation Index became available on magnetic tape. Later 
it was released on CD-ROM, along with the Social Sciences and Arts & Humanities citation 
indexes, before it emerged as we know it today – the Web of Science, the core database in ISI 
Web of Knowledge. The tool which Garfield had envisioned in 1955, was finally realized, and 
today citation indexing allows researchers across the world to further their studies and 
evaluate their work (Yancey, 2005). In today’s scientific publishing you can search in 
citations, quickly determining who is citing, and where citations have been cited before 
(Bruhns, 2010, p. 14). Citation analysis is quite common today. One of the reasons is the idea 
that receiving a lot of citations is seen as a sign of quality (Bruhns, 2010, p. 17). 
 
2.3 IMPACT FACTOR 
Indexing scholarly work by citations allowed researchers to track what other works a 
paper was referencing. As well as keep a count of how many times other people had cited a 
paper. By counting these citations you had a way of measuring the impact factor. The impact 
factor became an indicator of quality to more influential works. (Yancey, 2005) 
The Journal Impact Factor was created by Irving H. Sher and Eugene Garfield. The idea was 
to give smaller journals a way to stand out against the bigger ones. So instead of measuring 
the publication count, they would measure the citation count. This allowed for the ranking of 
journals and authors based on their citations, in order to determine their impact. The journal 
impact factor is calculated by the number of times all items published in the journal in a two 
year period is cited by indexed publications, divided by the total number of citable items by 
the journal in the same two-year period. The two-year period, which the calculations are 





use for the journal impact factor is for researchers who can use it to discover where to find the 
current reading list of their field, or for information 
analysis and bibliometrics by tracking bibliometric 
and citation trends and patterns. It is also there for 
librarians to help them decide which journals to 
purchase, or for authors trying to decide where to 
publish their articles. In other words higher impact 
might be seen as more prestigious. (Garfield, 2006b)  
The level of prestige associated with a higher journal 
impact factor is not without its critics. Many feel that 
too much weight is put on the impact factor.  
 
2.4 MOTIVE FOR CITING 
In 1978 Janet Beavin Bavelas at the University of Victoria, was concerned with the 
reasons for citing and the growing emphasis on citation counting. She viewed citations and 
the citation indexing as a way to trace an idea forward, however with some limitations.  One 
must keep in mind that a much-cited article will produce a lot of articles to read in order to 
trace the idea. Some of these citation sources will be irrelevant or trivial citations. The result 
is limited to the extent of the journals indexed. Clerical errors such as misspelled names listed 
as a separate author or article, or duplications will affect the citation count as well. These 
problems are relevant not only when tracing the underlying idea behind a citation, but also 
when using citations to measure scholarly impact. Bavelas claims that: “When citation counts 
are used in the service of the “sociology of knowledge” or to make decisions about 
individuals or departments, broader social issues are raised and require consideration at 
another level.” (Bavelas, 1978, p. 159) Bavelas questions the objectivity of this practice. This 
way of indexing citations may be objective, but the underlying initial reasons for citing may 
not be. “Only if this process is an objective one, free of subjectivity or social consensus, can 
data derived from it possibly have the same, desirable characteristic.” (Bavelas, 1978, p. 
160). When citing there is a plausibility that there is some level of personal bias or social 
pressure. At the extreme end of this bias could be the true scholarly impact, where there is a 
“As a general rule, the journals 
with high impact factors include 
the most prestigious. Some 
would equate prestige with high 
impact.”  





significant use of the cited authors theory, method or paradigm, but also the attempt to inflate 
others impact by for example citing the journals editors work, or boosting friends and 
colleagues. In between these two reasons Bavelas lay the idea of citing to show your 
knowledge of the field, and demonstrate your understanding of the fields’ most important 
work. This form of citing will be guided by a general, not always well-established consensus 
of what constitutes the important work in the field. It is expected that you know the most 
pertinent work in your field. Yet what is defined as the most pertinent work in the field tends 
to be what everyone in the field agrees is the most pertinent work, and may not always be 
connected to scholarly impact. Bavelas notes that this is often the case when writing, and both 
she and others make a large proportion of the citations in order to demonstrate an 
understanding of the field. (Bavelas, 1978) It is like Bellis describes the function of citations 
not only to call back to already established ideas and techniques, but also to demonstrate an 
intellectual link to the ones who came before you. The act of citing becomes a kind of 
currency where you borrow others credibility and use it to support and reinforce the view that 
you are advocating. The ability to cite others to strengthen your own claims, helps strengthen 
your credibility as an expert in the field (Bellis, 2009, pp. xvii-xix). If your goal is to simply 
strengthen your own claims by citing the sources you are expected to cite, there can 
sometimes be doubt if the article being cited was even read. In other word citations are not 
always the same as scholarly impact, because we cite for a variety of reasons. Using citation 
counts as a measure for scholarly impact only works if the citing author actually read and 
learned something that is important to bring forward in the article they are writing (Bavelas, 
1978). In “Stochastic modelling of citation slips” by Simkin and Roychowdhury they 
conclude that when many scientist write a manuscript they pick a selection of three papers, 
cite them and then simply copy a quarter of their references at random, meaning that a large 
number of citations can be a result of a stochastic process. They came to this conclusion by 
looking at the distribution of misprints and their ranking by frequency of their repetition. In 
the end they concluded that as many as 70-90% of scientific citations are copied from the 
reference list used in other papers, without having been read (Simkin & Roychowdhury, 
2005). Lie and Rousseau suggest that this might be pushing the stochastic methods too far. 





a reference is not the same as not reading the article (Liu & Rousseau, 2013). In terms of 
articles that are cited because of social consensus, one might suggest that articles that are 
cited, even if it is only because it is expected, does have scholarly impact because everyone 
agrees that the work is important in the field. This kind of vague and subjective social 
consensus is the very thing Bavelas is arguing against, since the original purpose of citation 
counting was to avoid this. The point Bavelas was making was that citations is not an 
objective indicator of scholarly impact as long as citations are made for other reasons 
(Bavelas, 1978). More people than Bavelas have been concerned with the motivation for 
citing, particularly citing in order to increase the visibility of your own work or your colleges. 
At its base the motive for citing are usually based upon developing, supporting, or applying a 
concept or a method. Motive for citing can also be to refute an article, claiming that its 
findings were wrong, but also to review an article as a relevant part of the literature. The other 
side of citing are the unethical reasons. Not just the social consensus citing that Bavelas talks 
about, but the conscious cross-citing of others, in a sort of if you cite me – I will cite you kind 
of way. This can make it difficult for new authors to get any recognition, since it makes it 
hard for them to be cited. The role of the Matthew effect plays a part in terms of citations. 
(Liu & Rousseau, 2013) It would seem as if those who already are highly cited are more 
likely to be cited again, making it harder for the lesser known scientist to get recognition. 
Even in the case of co-authors, the lead-author may not receive as much attention if one of the 
co-authors are more famous. People will often remember the name of the person that they 
have heard about before, over an unknown lead-author. (Merton, 1968). More citations means 
a higher impact factor. The idea of counting citations to measure impact, or how influential 
something is, is also, according to Bruhns not always correct since citations is not necessarily 
the same as impact. One reason for this is that citations are counted through scientific 
citations indexes, when in reality there exists other forms of citations. Scientific indexes such 
as Thomson Reuters Web of Science only indexes scientific articles. They exclude newspaper 
article and so on.  (Bruhns, 2010, pp. 21, 24) The main criticism against the impact factor is 
the fact that is so limited, yet so widely used today to measure import. Today the journal 
impact factor is used as concreate measure for scientific quality. Many journals use their 





is. Just because a journal has a high impact factor it does not automatically mean a high 
citation count for a single article published in that journal. The least cited articles are judged 
to be as important as the higher cited article in journals with a high journal impact factor. 
Which goes against the original purpose of the journal impact factor – to separate the more 
influential works from the lesser ones (Bruhns, 2010, pp. 270-276). The emphasis on the 
impact factor has led some to cite with impure motives. In 2013 Thomson Reuters suspended 
a number of Brazilian journals from their journal ranking. The journals in question had tried 
to artificially boost their own impact factor by publishing articles containing hundreds of 
references to papers in each other’s journals. By not citing articles in their own journals, but 
instead collaborating with other editors to cite articles in other journals the hope was to avoid 
detection from analysis that detect extreme self-citation. However they were discovered by 
Thomson Reuters who had developed a program that specifically target this type of 
concentrated bursts of citations from one journal to another, also known as citation stacking. 
Four out of 14 Brazilian journals had their impact factors suspended by Thomson Reuters. 
Mauricio Rocha-e-Silva, who got fired from his position as editor in chief from the journal 
Clinics, claimed that the citation stacking was a result of a growing frustration with Brazils 
increasing fixation on the impact factor. An agency in the Brazilian education ministry, called 
CAPES, use the impact factor of the journals that students publish in, to evaluate graduate 
programs. According to Rocha-e-Silva this means that most graduates will choose higher 
ranking journals to publish in, over emerging Brazilian journals that are in the lowest ranks. 
This in turn prevent local journals from improving, since it encourages local researchers to 
publish in high-impact journals. Rocha-e-Silva claims that this frustration from the editors 
tempts them to artificially boost their own journals impact factor. In the end Rocha-e-Silva 
acknowledge that what he did was wrong, but also that the journal impact factor scores are a 
bad way to judge a scientists work, and CAPES policy of doing so, is the real problem 
(Noorden, 2013). When commenting on the discovery of the citation stacking of the Brazilian 
journals, Marie McVeigh, the leader of Thomson Reuters annual report for journal citation 
patterns and impact factors, said that they cannot measure the motive or intent behind a 
citation, only the patterns and data of a citation: “Until we can algorithmically measure 





In fact some of the debate about citation analysis and its worth stems from the lack of 
knowledge about citers motives. Underlying reasons for citing can be political background, 
personal motives, or selected referencing in order to promote careers, departments, friends, 
bosses etc. This goes both ways in that one can under-cite without actually stealing results, 
but also over-cite in order to inflate the value of a college etc. (Brooks, 1985, pp. 223-225). 
In 1984 Terrence A. Brooks analysed current competing theoretical models used to describe 
citers’ motivations, coming up with seven key-reasons for citing: 
1. Currency scale: the citing to show how up-to-date the author is in their field. By 
reviewing what is most current, the author hopes that his own work is regarded as an 
advancement of his field. 
2. Negative credit: authors cite in order to criticize, correct, disclaim or dispute others 
work. Negative citing is disputed since some believe it does not exist, because 
erroneous material will be ignored and thus fades into obscurity. On the other hand 
work of little value, will not be criticized, but a highly cited paper may contain a 
fruitful error that makes a major contribution to the field. 
3. Operational information: authors cite in order to reference a concept or a theory, 
borrowing mathematical or physical techniques, references, results or conclusions 
from the cited paper.  
4. Persuasiveness: the author cite in order to support his own view, to persuade others 
and establish a knowledge claim.  
5. Positive credit: the citations pays homage, support claims, confirms data and gives 
credit. 
6. Reader alert: letting readers know about new, obscure sources, in order to provide 
background reading and identify original publications.  
7. Social consensus: introduced by Bavelas, as the social expectations and drive that 
makes us cite certain sources, based upon vague consensus in a field of study. 
(Brooks, 1985, p. 226)  
When doing a survey to categorize which of these reasons where most likely to be the 
drive behind citing, what stood out to Brooks was how much persuasiveness was a motive for 





motive for citing is to substantiate your own views, meaning that authors are likely to scour 
the literature for evidence in support of their own idea. The reason for citing which were the 
least common ones where the social consensus and the negative credit one. To Brooks this 
might be because many academic disciplines are loosely organized, therefor lack a strong 
social consensus, whilst the negative credit motive was almost completely ignored as a reason 
for citing. For many authors reader alert and operational information seemed like obscure 
motives for citing. Currency and positive credit might be stronger motives because of their 
possibility to act as surrogates for pervasiveness. In the end Brooks concludes that the citer 







3 METHOD: THE SUDBØ-CASE AND CITATIONS 
In his book Casestudier: forskningsstrategi, generalisering og forklaring, Svein S. 
Andersen defines case studies as “intensive qualitative studies of one or a few investigative 
unites.” Case comes from the Latin word “casus”, and it underlines the importance of a single 
instance – or a single case. In other word a case study generally focus on one action, one 
procedure, one statement or one turn of events etc. A case study is not based upon statistical 
procedures, but instead focuses on analytical reasoning combined with additional knowledge 
about empiricism and theory. (Andersen, 2013, p. 14)  
Case studies have grown in popularity since the 1980 because of the possibilities they 
give. Through as case study you gain context specific knowledge which can be typical and 
representative of a phenomenon (Andersen, 2013, pp. 23-26). The context, or case that I have 
examined is Jon Sudbø and his misconduct. I have outlined his background, mainly focusing 
on the events of 2005 and 2006, when he was under investigation for falsifying data in his 
research. Case studies are ideal for drawing conclusions in light of an analytical context, 
which allows you to generate theories in terms of developing terminology, hypothesis and 
casual mechanisms relevant to the social sciences. (Andersen, 2013, p. 26) By studying the 
Sudbø-case, and specifically doing a citation analysis of his retracted article, I hoped to say 
something about the phenomenon that is retracted articles, ultimately having developed a 
hypothesis to why retracted articles are cited. The citation analysis focused on how Sudbø 
was cited after retraction. The goal was to determine if there was a specific way of citing him 
that might justify the citations after retraction, or if the citations came from not knowing that 
Sudbø’s articles are retracted. 
 
3.1 CITATION ANALYSIS 
When doing a citation analysis Bruhns highlights its advantages by the fact that 
citation analysis are unobtrusive, in the sense that the people or the units that you are 
researching are not aware of this. Citation analysis are objective as well, though Bruhns 
emphasise that this is only true if you use a citation index such as ISI Web of Science, since 





limitations. Literary references does not show the complete scientific process. Citation 
analysis are therefore not ideal for tracing the cognitive influences of a specific scientific 
work. (Bruhns, 2010, pp. 265, 362) Citation analysis as a method is debated because it 
emphasise the idea that influence is the same as quality. In modern science the value of 
scientific work is based on how essential it is for further work. (Bellis, 2009, pp. 244, 336) 
Yet most agree that bibliometrics and citation analysis is not ideal for the evaluation of 
individual scientists or departments, at least not as the only criteria for evaluation. The use of 
citation counting does for example not provide you with any knowledge about work that is 
uncited. Too much emphasis on citation can at its extreme cause a change in citing behaviour 
as citers motives may change. (Bruhns, 2010, p. 363) Citations counting can however show 
patterns in citation that are ideal in finding out why retracted articles are cited. 
 
3.2 CITATION COUNT 
The website Retraction Watch is a blog which keeps track of the retraction of 
scientific articles. The purpose of the website is to make people more aware of the retractions 
in scientific publishing. One of the ways of doing this is by keeping a list of highly cited 
retracted articles. What is notable about many of these retracted articles is that they are still 
cited, even after retraction (Oransky, 2015). The most cited article “Visfatin: A protein 
secreted by visceral fat that mimics the effects of insulin” (Fukuhara et al., 2005) have, based 
on numbers from Web of Science, 1279 citations, where 776 of them are after retraction. Jon 
Sudbø and his articles are not cited as much, but he has still received citations even after 
retraction. The most cited article of Sudbø is “DNA Content as a prognostic marker in 
patients with oral leucoplakia” (Sudbø et al., 2001). It has 188 citations according to Web of 
Science. Of these 188 citations 40 of them came after retraction.  
The citations after retraction could be attributed to people commenting on Sudbø 
committing research fraud. The Sudbø-case received a lot of publicity, so many people cite 
Sudbø in the context of talking a about research misconduct. On the other hand some of the 
citation use Sudbø as source, without acknowledging the retraction. How common this is I 
have determined by studying the frequency and nature of the citations of Sudbø’s work after 





Sudbø’s work has been retracted? Or do they simply use him as a legitimate scientific source? 
By comparing Sudbø’s most cited article published in New England Journal of Medicine in 
2001 (Sudbø et al., 2001) and retracted in 2006, to the Lancet article (Sudbo et al., 2005) that 
finally exposed Sudbø, I will see if there is a difference in the way that these two articles are 
cited. Both the New England Journal of Medicine (NEJM) and the Lancet are COPE 
members. This means that they should adhere to the COPE retraction-guidelines when 
retracting. The aim of the analysis is to determine how Sudbø is cited after retraction and how 
different databases adhere to retraction guidelines, in order to exemplify the effect of 
retractions on the literature. 
I used Web of Science and Google Scholar to determine which of Sudbø’s articles was 
the most cited one. “DNA Content as a Prognostic Marker in Patients with Oral Leucoplakia” 
was cited 188 times in Web of Science, and 327 times according to Google Scholar. The 
Lancet article “Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested 
case-control study” is cited 49 times in Web of Science and 102 times in Google Scholar.  I 
began by determining the yearly citations of the two articles through Web of Sciences Citation 
Report feature, to see how the two articles were cited both before and after retraction. 
I used both Web of Science and Google Scholar to count the citations, because Web of Science 
only indexes scientific publications, while Google Scholar indexes more broadly. This means 
that the citation count from Google Scholar is higher, but also from less reliable sources. 
Afterwards I compared the differences between the Web of Science and the Google Scholar 
results.  
I chose to define the search from 2007 to 2016, in the hopes of excluding articles who 
cited Sudbø before the retraction. However, there were some articles that fell into what I 
would define as a grey area. These were articles that were submitted for review after the 
Lancet incident. These articles were submitted, and sometimes accepted and published in the 
time between February 2006 and November 2006. The Sudbø-scandal began in January of 
2006, when the Lancet article finally was publicly exposed. On this basis one could assume 
that some of the people involved in the publishing process, be it the authors, reviewers or the 
editors, should have been aware of the Sudbø-investigation, and perhaps taken the time to 
include an acknowledgment in their papers. However, since the “DNA Content as a 





November 2nd of 2006, when every co-author except for Sudbø’s brother, Asle Sudbø, and 
Sudbø himself called for a retraction, I have given them the benefit of the doubt and placed 
them in the grey area column. Some articles that cite Sudbø I did not have access to due to 
language barriers, since I am limited to English and the Scandinavian languages, Norwegian, 
Danish and Swedish. A very limited number of articles were inaccessible to me because it 
was content which I would have to pay for, meaning that I could only check the articles 
available to me via to the access granted to me as a student at the University of Tromsø – The 
Arctic University of Norway (UiT). 
 
I classified the citations into the following categories: 
1) Debate: Citations who cite in order to talk about the fraud or the Sudbø-case: these 
include a lot of ethical debates about scientific misconduct, who discuss the 
Sudbø-case and how it happened. 
2) Does not mention retraction: Citations who use Sudbø as a source without 
acknowledging retraction. 
3) Mentions retraction: Citations who reference Sudbø, but acknowledge retraction, 
these were often literary reviews concerned with the current status of the field. 
4) Grey area: articles submitted and published after the investigation of Sudbø 
began, that does not acknowledge the ongoing investigation of Sudbø.  
5) No access: Citations which I did not have access to because of language barrier or 
because they cost money. 
Finally I checked different databases to see how they had handled the two articles in terms of 
the retractions, and if they had adhered to the recommendations of the COPE guidelines for 
retraction. I chose to check Web of Science, Google Scholar, PubMed, Scopus, ProQuest and 
Medline since these are some of the most commonly used databases in terms of scientific 
research. What I looked for was if the retraction was noted in the article search record, or 
noted in the search record title, whether the database linked to the retracted version of the 
articles, and if the linked to version (PDF) of the articles showed that it was retracted. The 
final search through the citations were conducted in week 16, 2016, while the checking of 





4 JON SUDBØ: RISE AND FALL 
Jon Sudbø graduated at the top of his class as an oncologist (cand.odont) in 1985 and 
as a doctor (cand.med) in 1994. In 1993, 
Doctor Albert Reith recruited him to conduct 
a study determined to find methods to predict 
oral cancer. Sudbø was given a three-year 
research grant from the Norwegian Cancer 
Society to work on his doctoral project, with 
Reith as his main supervisor. The project took 
place from 1993 to 2001. (Ekbom et al., 2006, 
p. 45) During this time Sudbø along with a 
number of co-authors wrote and published 
several articles in major and prestigious 
scientific journals such as New England 
Journal of Medicine, The Journal of Clinical 
and Oncology. 
On the 15th of October 2005, The 
Lancet published the article “Non-steroidal 
anti-inflammatory drugs and the risk of oral 
cancer: a nested case-control study” written 
by Jon Sudbø as the main author along with 
thirteen co-authors (Sudbo et al., 2005). The 
findings of the article did not go unnoticed 
since they claimed that the long-term use of 
non-steroidal anti-inflammatory drugs 
(NSAIDs) would reduce the chance of oral 
cancer (Sudbo et al., 2005). NSAIDs are 
drugs who offers pain relief, reduces fever and 
inflammation, such as ibuprofen, naproxen 
and aspirin. However the article also claimed 
that the use of these common painkillers 
OCTOBER 2005: The Lancet 
article is published. The article 
claims that common painkillers 
can prevent oral cancer, but 
increases the risk of heart 
disease.  
DECEMBER 2005: Camilla 
Stoltenberg reads and begins to 
question the article, raising her 
concerns to others. 
JANUARY 2006: Lars Vatten 
sends an e-mail to Jon Sudbø, 
where he questions the findings 
of the article. 
10TH OF JANUARY: Meeting with 
Sudbø, his main supervisor 
Albrecht Reith and the 
Norwegian Cancer Registry. 
12TH JANUARY: Sudbø admits to 
committing research fraud. 
JUNE 2006: The report from the 
research committee is released, 
concluding that most of Sudbø’s 
work is based on falsified data. 
Sudbø loses his job, his right to 





would increase the risk of heart disease. (Tunstad, 2011, p. 185) The public reacted 
accordingly and people became afraid to use these painkillers, and reports kept coming in 
about patients 
changing to different, 
harder drugs, because 
of fear of using 
NSAIDs (NTB). The 
findings of the article 
did not only bring 
worry and upset to the 
public, fellow scientist 
were beginning to 
raise questions of their 
own. One of these people were Division Director with the Norwegian National Health 
Institute, Camilla Stoltenberg. In December of 2005 she was reading the Lancet article and 
could not for the life of her understand how Sudbø had reached some of his conclusions, 
when the material he was basing his findings on did not exist. Sudbø had used Norwegian 
health databases in his study. From the database CONOR (Cohort of Norway) he had 
collected 454 cancer patients, who were registered as heavy smokers. As a control group he 
used 454 noncancerous heavy smokers from the same database. The problem was that 
Stoltenberg was legally responsible for the data in the CONOR study. She knew that Sudbø 
did not have access to the data, since the data was yet to be released. Not only that, the way 
Sudbø used and describe the CONOR data was completely wrong. Sudbø claimed to have 
access to data about the non-steroidal anti-inflammatory painkillers from the Norwegian 
Prescription Database, data whom Stoltenberg also noticed Sudbø was describing wrong. 
Errors Sudbø made included saying that the CONOR data went all the way back to 1975, 
when in reality they were exclusively collected in the 1990s. The data from the Norwegian 
Prescription Database, Sudbø claimed dated back to the 1970s, when in actuality the 
Prescription Database was not created until 2004 – after Sudbø’s collection of data for the 
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article. (Tunstad, 2011, pp. 188-189) Stoltenberg conferred with fellow scientist at the 
Norwegian Institute of Public Health. The Cancer Registry of Norway, which Sudbø had 
listed as the supplier of the material concerning the cancer cases, was also contacted. They in 
turn contacted Professor Lars Vatten MD at The Norwegian University of Science and 
Technology (NTNU), who was a member of the management group for CONOR. (Ekbom et 
al., 2006, p. 43) Upon reading the article Vatten reacted in disbelief, acknowledging that as 
groundbreaking as Sudbø’s finding may be – none of it was true! Yet Sudbø was given the 
benefit of the doubt. Surely he had simply made a mistake? A huge one at that, to Stoltenberg 
this seemed more likely than the idea that Sudbø intentionally had fabricated data and 
committed fraud. Vatten decided that the best way to gain some clarity in the situation was to 
go directly to the source. On the 5th of January 2006 he sent an e-mail to Jon Sudbø asking to 
know more about where the materials of his study was coming from. Upon further 
investigation Vatten discovers that the Norwegian Data Protection Authority had not given 
any permission to Sudbø or his colleagues to use data from the different registries Sudbø 
claimed to have had access to. The Norwegian Cancer Registry had never even received an 
application to deliver the data Sudbø claimed to have. It is was soon becoming more and more 
clear that it was not a case of a naïve scientist who had made an error. No it was a case of 
dishonesty and fraud. On the 10th of January, 
Vatten, along with colleagues, meet with Jon 
Sudbø and Albrecht Reith at the Norwegian 
Cancer Registry. They questioned Sudbø, and 
they agreed that Sudbø should give up a disc 
containing all the relevant information to the 
case. Sudbø seemed tired and left halfway 
through the meeting. On January 12th Sudbø 
comes clean and admits that the data used in 
the Lancet article is not true. (Tunstad, 2011, 
pp. 190-192) On the 18th of January 2006 the 
Investigation Commission in charge of finding 
out the extent of Sudbø’s fraud was appointed 
by Rikshospitalet – Radiumhospitalet MC and the University of Oslo.  
“On the 12th of January, Jon Sudbø 
admitted to his superiors at the 
Norwegian Radium Hospital that he 
had fabricated the computer file 
which the science results presented in 
the Lancet article was based upon. 
Which means that the alleged 
patients which the analyzed data 
originates from are fictitious” 
(Ekbom, Helgesen, Tverdal, Lunde, & 





4.1 THE SUDBØ-COMMISSION 
Sudbø’s employers, Rikshospitalet – Radiumhospitalet HF and the University of Oslo, 
appointed an investigation commission to determine whether Sudbø had committed research-
fraud or not. The committee was established on the 18th of January 2006, releasing its 
findings on the 30th of June 2006. After admitting to the Investigation Commission that the 
patients in the Lancet article were fictitious, Sudbø also confessed that there were deficiencies 
with two of his other articles:  
 Sudbø J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold 
R, Sigstad E, Davidson B, Reith A, Berner A. Risk markers of oral cancer in clinically 
normal mucosa as an aid in smoking cessation counseling. J Clin Oncol. 2005 Mar 
20;23:1927-33  
 Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-
Naggar A, Risberg B, Evensen JF, Reith A. The influence of resection and aneuploidy 
on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 1;350:1405-13.  
In light of this, and the hubbub of the Lancet article, the Investigation Commission decided it 
was necessary to investigate all of Jon Sudbø’s scientific production and his published work. 
The Commission set forth to investigate the role of Sudbø’s co-authors and contributors as 
well. The goal was to find the answer to some key-questions: 
 Were the patients who allegedly have been studied real or fictitious? 
 Was patient data manipulated? 
 Did serious methodological flaws exist? 
 Was there evident and serious flaws in the research reporting? 
 Were there other serious breaches of scientific practice/good research practice? 
(Ekbom et al., 2006, p. 44) 
The Commission began by mapping the data which was the basis for Sudbø’s PhD 
degree project. This was because the material collected for the PhD had been the basis for 
Sudbø’s subsequent research (Ekbom et al., 2006, p. 44). 
In total the Commission went through Sudbø’s entire scientific body of work from 1993 to 





cooperative, submitting voluntary written statements. The Commission gathered information 
from all relevant institutions and partners and compared every available data lists and 
published research results to judge whether the underlying data, which Sudbø’s published 
work was based upon, was real. The Cancer Registry of Norway, which Sudbø cited as a 
source for his data collecting, also conducted their own internal investigation. Both the 
Sudbø-Commission and the internal investigation of the Cancer Registry came to the same 
conclusion: 
“the data underlying parts of Sudbø’s PhD project, as well as several other publications, are 
not sufficiently consistent with the actual facts the Commission has found it reasonable to take 
into account.” (Ekbom et al., 2006, p. 6) 
In conclusion the Commission determined that the errors they found were too grave to be 
anything other than fabricated or manipulated to fit the desired findings of Sudbø. The end 
result was that the doctoral dissertation as well as all publications based on the same raw 
material, which was most of them, was retracted. In short the bulk of Jon Sudbø’s 
publications was based upon fabrication 
and manipulation, and therefore invalid. 
Jon Sudbø was given the chance to read 
and comment on the findings of the 
Commission, but failed to provide any 
information that would change the 
conclusion of the Commission. They 
concluded that Sudbø acted alone in his 
misconduct, since he maintained full and 
sole control of the underlying data. This 
level of independence was criticized by 
the Commission, and they pointed out 
that the lack of supervision from the Norwegian Radium Hospital was one of the reasons to 
why Sudbø was able to get away with his misconduct for so long. The co-authors had little to 
no knowledge about the underlying data material, and most communication that took place 
went through Sudbø. Therefore the co-authors had little opportunity, or reason, to check the 
data, or to check who contributed with what. However the Commission pointed out that there 
«…the Commission has noted that colleagues, 
researchers, clinicians and individual patients have 
probably used Sudbø's research results, and it is 
therefore reasonable to assume that some of 
them have been affected. The serious implications 
of this must have been obvious to Jon Sudbø right 
from the start.” 





were plenty of signs which people should have picked up on, be it the co-authors, supervisors, 
superiors, opponents, colleagues and others, ultimately calling it a systemic failure, holding 
the institutions responsible. They recommend that the institutions in the future take more 
responsibility for instructing their researchers in proper scientific conduct, as well as 
exercising some level of verification and control in the research process. The Commission did 
not view it as their task to assess the ramifications of Sudbø’s fraud, but they did point out 
that colleagues, researchers, clinicians and patients had probably used Sudbø’s research 
results, meaning that at least some of them had been affected (Ekbom et al., 2006, pp. 5-8). 
 
4.2 THE MISCONDUCT 
The Sudbø-Commission concluded that all of Jon Sudbø’s published articles where invalid, 
except for four original articles, mainly concerning lesser reviews and letters of less scientific 
value, as well as works in which Jon Sudbø was only a co-author, i.e. publications which 
mainly have been prepared by others (Ekbom et al., 2006, p. 91). 
One of the articles that underwent serious scrutiny from the Commission was, Sudbø’s most 
cited article to date: “DNA Content as a Prognostic Marker in Patients with Oral 
Leukoplakia”, published 
in the prestigious New 
England Journal of 
Medicine (NEJM) (Sudbø 
et al., 2001).  
On the 9th of February 
New England Journal of 
Medicine (NEJM) also 
published an expression 
of concern, following the 
investigation of Sudbø.  
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In November 2006 the article was officially retracted on the request of all of the co-authors, 
only opposed by Jon Sudbø who did not agree with the findings of the Sudbø-Commission 
(Curfman  et al., 2006b). 
The committee focused its examination on the article because they considered it the most 
important article of Sudbø’s career, and it was the basis for several subsequent articles, as 
well as a similar article published in the same journal in 2004. The focus of Sudbø’s study 
was that by doing a ploidy analysis and comparing it with cancer development Sudbø 
hypothesized that one could use the ploidy in cells from white patches as an indicator of 
future oral cancer; a very serious form of cancer. The result of Sudbø’s research had left him 
with an impressively good method to predict oral cancer for people with white patches. The 
extensive discrepancies found by the Commission lead them to conclude that: “this 
sensational research result no longer have credibility” (Ekbom et al., 2006, p. 81).  
Sudbø’s study was based upon patient material consisting of 150 patients. The findings of the 
committee did however revealed several fundamental problems with the New England 
Journal of Medicine 2001 and 2004, as well as a range of other articles: 
 The same patient occurred multiple times. The mentioned 150 patients was at most 
141, though it was difficult for the Commission to determine the actual number. 
 A large number of patients should have been excluded from the study, since they 
already had existing or prior cases of oral cancer. At least 69 people should have been 
excluded. 
 Ploidy analysis was not made for all patients. The Commission was only able to 
retrieve ploidy analysis from 69 of the observations, stemming from 65 different 
persons. They estimate that over 150 ploidy analysis had been performed, but the 
same patients appeared several times. 
 The age distribution of the material did not correspond to each other from article to 
article. In the NEJM article from 2001 it claims that the material dates back to 1982 to 
1995, and in other articles he claims that it dates back to 1976 to 1995.  
The Commission viewed the failure to exclude patients from the study as the most serious 
one. When over half of the patient material should have been excluded from the study, the 





Sudbø, based upon this material was also invalid. All publications based upon this 
research should therefore be retracted (Ekbom et al., 2006, pp. 58, 86-88).  
 
4.3 DISTRIBUTING THE BLAME 
The Commission criticized several people for not catching Sudbø, ultimately blaming 
the institutions and their routines for letting Sudbø get away with his misconduct for so long. 
The media was quick to question the role of peer-reviewers and asked why they had not done 
their job.  
Once people started to take a closer look at the Lancet article the cracks where easily spotted. 
Which led many to question the work of the peer-reviewers. When talking about the Sudbø-
fraud in 2006, Paul Gerber use the Sudbø-case as an example of how scientific frauds 
sometimes can slip past peer reviewers. A reason he gives is the fact that is the inherent trust 
in the data, which a reviewer must display, since, like in the case of Sudbø, the data involves 
a specialized area of medicine and to replicate the data would be time-consuming and 
unrealistic (Gerber, 2006). In terms of the Lancet article, all fault for not discovering the 
fraud does not lie with the peer-reviewers. One of the peer-reviewers was the Danish 
professor Henrik Toft Sørensen, who worked as the Head of Department of Clinical 
Epidemiology at Aarhus University Hospital. He did in fact warn the editor of the Lancet, 
Richard Horton, against Sudbø’s article, only to be ignored. The impression Sørensen had 
after reading the article was that something was off. Sørensen noticed that the article referred 
to data registries which were not available at the time of Sudbø’s study. “I had strong 
reservations against the quality of the article” and his “alarm bells were ringing” Sørensen 
said to forskning.no when discussing the case back in 2011 (Hildebrandt, 2011). Ultimately 
Sørensen recommended that the Lancet should not publish the article. The editor, Horton, 
chose to ignore that recommendation. Something he easily glossed over when asked how the 
Lancet had not caught Sudbø’s manipulations. He claimed that the peer-reviewers had 
unanimously approved the article for publishing. (Hildebrandt, 2011) Horton instead blamed 
the co-authors who he claimed they had had extensive contact with about the data and the 





been, claiming that it was “incomprehensible how not one of the co-authors knew something” 
(Hafstad, 2006). 
On the day before the 
Sudbø-commission began 
their work, Horton published 
an expression of concern 
about the Lancet article. 
Before that he had marked 
the case of Sudbø as “the 
biggest scam from a scientist 
the world had ever seen.” 
Before concluding that the 
Lancet had followed all of 
the routines to ensure 
quality. (Hafstad, 2006). Many feel that this was his way of taking the spotlight away from 
himself, in order to distribute the blame elsewhere. However blaming the peer-reviewers, or 
the co-authors did not exonerate him completely, since he glossed over the fact that the 
Lancet had been in a hurry to publish the article. Michael Thun, an epidemiologist at the 
American Cancer Society was another person who had advice against the article, because he 
was not given enough time to check some of the discrepancies he had discovered with the 
article. Horton later denied any claims that he had been warned, accepting no responsibility 
(Tunstad, 2011). 
Horton did however have a point, because the scientific fraud could have been dealt 
with sooner. Already in 2001 when the NEJM article (Sudbø et al., 2001) was first published 
a duplication of microscopy pictures was discovered in the article. Jon Sudbø explained that it 
was an honest error, and the mistake was not corrected or reported to the journal. If more 
action had been taken back then, the scandal that followed in 2006, might have been avoided 
(Oksvold, 2016). Sheldon Kotzin use this to point out that if an author claims that their 
instance of fraud is a one-time thing, a common error or an isolated event, that is not good 
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enough and will require further investigation. “You can’t afford to give a scientist the benefit 
of the doubt, even someone of Sudbø’s status…”(Kotzin, 2007). 
Erik Tunstad writes that the only person to be blamed for the misconduct is Jon Sudbø 
himself, condensing the misconduct to the fact that some people are rotten apples and even 
scientist sometimes cheat (Tunstad, 2011, pp. 10-11). The Sudbø-committee blamed the 
institutions and Sudbø’s advisor, Albrecht Reith, for not having the proper routines and 
control of what Sudbø was doing. Horton blamed everyone, but himself, yet the Sudbø-
committee concluded that Sudbø acted alone, and the co-authors had little to no knowledge of 
what was going on. The journals should have caught the misconduct, but the rushed treatment 
of the Lancet article proved that the peer-review is not always a watertight system, and 
sometimes articles that should not be published are. The purpose of retractions is to act as a 
corrective measure, but for that to have effect retractions must be handled correctly. 
 
4.4 RESULT: HOW IS SUDBØ CITED?  
The purpose of the citation count and analysis was to determine how two of Sudbø’s 
retracted articles were cited after retraction. The two articles in question was his most cited 
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4.4.1 CITATION REPORT OF THE TWO ARTICLES 
The Citation report from Web of Science revealed that Sudbø is still cited, with one 
citation for each of the articles in 2016, 10 years after the retraction. In fact the only year the 
NEJM (Sudbø et al., 2001) article did not receive any citations was in 2013. His most cited 
article from NEJM (Sudbø et al., 2001), had a predictable drop in citations after 2006 and the 
retraction. Yet the article has an average of 4 yearly citations after retraction, compared to the 
average of 24.7 citations before retraction. The article from the Lancet (Sudbo et al., 2005), 
which exposed Sudbø shortly after being published, received most of its citations in 2006. 
This is to be expected, since the article had very little time to gain any traction before it was 
exposed, compared to the NEJM article. This goes hand in hand with the results of the 
citation count, which revealed that most of the citations connected to the Lancet article, were 
in terms of debate, and reporting about the fraud, using Sudbø as an example of scientific 
misconduct.  
In total the two articles are cited 237 times in Web of Science, with the exclusion of one 
citation, because it linked to nothing, leaving the total count to 236 citations. Out of these 
citations 83 citations for the two articles combined, came after retraction.  
4.4.2 WEB OF SCIENCE AND GOOGLE SCHOLAR CITATION COUNT 
The NEJM article is cited 40 times after retraction, and the Lancet is cited 43 times, when you 
include the citations from 2006, which falls into the grey area.  
In Web of Science the NEJM article were cited in the debates (n = 4), does not mention 
retraction (n =16), mentions retraction (n = 5), grey are (n = 6), and the no access category (n 
= 5). The Lancet article was cited in debate (n = 32), does not mention retraction (n =3), grey 
area (n = 4), and the no access category (n = 1). In Google Scholar the citation count was 
higher with the total number of citations for both articles at 429 times. The NEJM article was 
cited 327 times, and the Lancet article was cited 102. After retraction the combined number of 
citations were 160, with the NEJM article cited 104 times and the Lancet article 56 times. The 
citations came from a number of sources, but the majority was from peer-reviewed journal 
articles. The NEJM article were cited in the debates (n = 10), does not mention retraction (n 





access to (n = 33). The Lancet article was however only cited in debate (n = 33), does not 
mention retraction (n = 4), grey area (n = 2), and the ones inaccessible to me (n = 17), with no 
citations in the mentions retraction category (n = 0). 
The results from the Web of Science search and the Google Scholar search are similar, but 
Google Scholar did of course yield a larger number of citations. The one that comes closest to 
each other is the Lancet article, who received almost the same amount of citations in Google 
Scholar and Web of Science in the debate category. Also notable is the amount of citations 
which I could not access in Google Scholar compared to Web of Science. This is to be 
expected since Web of Science indexes scientific journals, compared to Google Scholar who 
indexes much more broadly. Since Thomson Reuters only indexes journals that are members 
of ISI, the credibility of the citing sources is generally considered to be higher than from 
Google Scholar. Other than that the main difference between the Web of Science citation 
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In Web of Science 44% of the citations of 
the NEJM article, did not mention 
retraction, compared to the 14% that did. 
An overwhelming amount of the citations 
of the Lancet article, 76%, were citations 
that talked about the Sudbø-fraud, 
commenting on his misconduct. The 
NEJM article is less used to exemplify 
misconduct, with only 11% using it for 
debate. This is to be expected since the 
publicity surrounding the Lancet article 
was much higher. This might also be the 
reason to why 17% of the NEJM citations 
falls into the grey area, where people had 
the time to include a comment about the 
Sudbø-incident but did not. Only 10% of 
the Lancet articles citations falls into the 
grey area. 
From Google Scholar 30% of the ones who 
cite the NEJM article, does not mention the 
retraction. 19% does mention retraction, 
and 9% use the article to talk about the fraud or debate Sudbø. Many of those debating Sudbø 
talked about the photo fraud, and how one can proceed to avoid photo manipulation in the 
future, since one of the problems with the NEJM article was the fact that there was 
photoduplication, with the same image appearing twice, but reported as different images. As 
with the search from Web of Science, there is a clear difference between the citing of the two 
articles. With the Lancet article 59% of the citations received after retraction is due to people 
talking about the fraud and misconduct. In total the Lancet article was cited 102 times, which 
means that the Lancet article is received more citations after retraction. Of the citations of the 
Lancet article only 4% of them were so-called “grey are” citations. This could be the result of 



































concern almost immediately after the news broke. The expression of concern for the NEJM 
article was published in February 2006 
(Curfman , Morrissey , & Drazen 2006a), with 
New England Journal of Medicine officially 
retracting the article in November 2006, on the 
request of the co-authors, which means that 
many might have been waiting for the 
conclusion of the Sudbø-committee, before 
taking action (Curfman  et al., 2006b). This 
might explain why a larger percentage of the 
citations of the NEJM article falls into the “grey 
area”, with 17% from Web of Science, and 10% 
from Google Scholar. In fact even after 
retraction more people still cite the NEJM article 
as a legitimate source, without mentioning the 
retraction. Which could be a result of people 
simply not being as aware of the retraction of 
the NEJM article as the Lancet article. There 
was quite a large number of articles which I did 
not have access to mainly due to language 
barriers. Therefore the result might have looked 
differently if I had known the content of these 
articles. The different languages citing Sudbø 
ranges from Italian, Dutch, French, Spanish, 
German and several Asian languages. I have no 
doubt that some of these sources are citing 

































4.4.3 RETRACTIONS IN DIFFERENT DATABASES 
If you look past the larger amount of press that the Lancet article received there might be 
other factors who determine the citation count, such as the handling of the retraction in 
different databases. The search through the different databases revealed that not everyone 
were handling the retractions according to the COPE-guidelines. When searching through 
Web of Science, Google Scholar, PubMed, Scopus, ProQuest, and Medline, all of the 
databases, except for Google Scholar, noted in the article search record that the two articles 
were retracted. This notice included any indication within the database search record that the 
article was retracted. However only Web of Science noted in the search record title that the 
articles were retracted. Google Scholar only did this for the Lancet article. Fortunately with 
the NEJM article all of the links to the PDF version showed that the article was retracted, but 
with the Lancet article PubMed, Scopus and Medline linked to PDF versions that did not 
show that the article was retracted. In Scopus you have the option to go to the publishers’ 
version of the article, this takes you directly to the journals version, and both The Lancet and 
New England Journal of Medicine have published retractions to the articles. Since it is 
indicated in the search record for all, but Google Scholar, with the retractions and expressions 
of concern included in the search result, you would have to have pretty severe tunnel vision to 
make your way to the PDF.  
  
  
Noted in Article Search 
record 
Noted in Search Record 
Title 
Link shows retraction 
(PDF) 
Database NEJM (2001) The Lancet (2005) NEJM (2001) The Lancet (2005) NEJM (2001) The Lancet (2005) 
Web of 
Science √ √ √ √ N/A N/A 
Google 
Scholar X √ X √ √ √ 
PubMed √ √ X X √ N/A 
Scopus √ √ X X √ X 
ProQuest √ √ X X √ X 
Medline √ √ X X √ X 





The redeeming factor for Google Scholar is the fact that the results link directly to the 
journals site, and they have posted the retraction. If you however only look at the article, 
without glancing at any of the other results you do have a small chance of making your way to 
the PDF version of the article, and in the case of the Lancet article this means that you might 
miss the retraction. If you have a hardcopy if the article and are only doing a preliminary 
check to look for retractions, you are less likely to make your way to the PDF-version, 
therefor you might miss the fact that the articles are retracted in Google Scholar. In other 
words for these two article you would be best served to use Web of Science to determine the 






5 DISCUSSION: WHY ARE RETRACTED ARTICLES CITED? 
The result of the citation count from Sudbø’s two articles, shows that sometimes it is 
necessary to cite retracted articles. Many of the citations for the Lancet article falls into the 
debate area. From the Web of Science citation count we can see that 76% of those who cite it 
use it to talk about the misconduct. If we were to apply the same reasons for citing as Brooks 
did, this would mean that a lot of the citations falls into the negative credit citing category. A 
category Brooks experienced that very few citer would put their citing into (Brooks, 1985). 
The crucial difference here might be the fact that the content of Sudbø’s articles have been 
proven to be wrong, which was the whole reason for the retraction. So one of the most 
prominent services these article can provides us with today is the ability to learn from them, 
not from the content, but learning what not to do. The point of retractions is to correct the 
science. Articles that are retracted are generally labelled as having little value, and ideally 
they should fade into obscurity. By using it to talk about scientific misconduct you are giving 
the article a new value, which means that this type of negative credit citing is a positive thing.  
The problem are the citations who cite after retraction without mentioning the 
retraction. The results of the Web of Science citation count showed that as much as 44% of 
the ones citing the NEJM article cite it without mentioning retraction. In other words they 
largely use it as persuasion. They cite Sudbø in order to support their own views and findings. 
This is the kind of citing that a retraction is meant to discourage.  
Yet the citations for Sudbø did drop after citation. The NEJM article had an average of 
24.7 citations before the retraction, and an average of about 4 yearly citations after retraction. 
The Lancet article was not cited until after the scandal broke, the difference in how the two 
articles are cited, both in the Web of Science count and the Google Scholar count, are 
therefore to be expected. The high publicity the Lancet article received may lend itself 






5.1 REASONS FOR CITING RETRACTED ARTICLES 
When going through the literature some primary reasons for citing retracted articles 
stood out. One main issue is the importance of making the retractions known (van der Vet & 
Nijveen, 2016). This means to follow the COPE-guidelines for retraction, since significantly 
fewer retracted articles with the retraction notice freely accessible were cited, then articles 
where the retraction notice was not easily available (Balhara & Mishra, 2014). In the case of 
Sudbø’s retracted articles this could be part of the problem. Both the New England Journal of 
Medicine and the Lancet have issued retractions according to the COPE-guidelines. The 
retractions are clearly defined as retractions and they are linked to the original article, who is 
marked as retracted. The retractions were published promptly on the website of the journals in 
order to minimize harmful effects. It is clearly stated who is retracting the articles, with the 
reason for retraction stated as well. However as we can see from my search through the 
databases, not all of the databases are in compliance with the guidelines. Only Web of Science 
ticks every box as they had noted of the retraction in the article search record, and search 
record title. The link they provide you with is to the journals version of the article, which is 
clearly marked as retracted. Only Google Scholar failed to note of the retraction in the article 
search record for the NEJM article. This is the article that is most cited without 
acknowledging retraction. As many as 44% have managed to miss the fact that the article is 
no longer part of the chronicles of science. An excuse for this can perhaps be found in the 
databases handling of the retraction. The NEJM article was published back in 2001. That is 15 
years ago. The idea that some scientist have filed away a hardcopy of the article, in order to 
use it in the future is not so farfetched. Since the retraction warnings are added inconsistently 
in the databases, said scientist may have searched for the article in say Google Scholar, only 
to not be warned that the article is retracted, and is therefore using it as valid research which 
they can use in their persuasive citing (van der Vet & Nijveen, 2016), (Brooks, 1985). This 
incomplete, uninformative retraction notice can be a direct cause for the citations of retracted 
articles. One must also accept the possibility that if most of the people who cite do it for 
persuasiveness they might not be to inclined to look for evidence of retractions once they 
have found a source which describes something they agree with. A quote from George 





The moment we want to believe something, we suddenly see all the arguments for it, 
and become blind to the arguments against it. (Shaw, 1928) 
So if you have filed away a hardcopy of something, for future research, you might be content 
with that, and not bother to look for retractions. Or perhaps scientist are too trusting, 
believing in the honesty of others, and like Fang and Casadevall said: “most scientist feel that 
research misconduct is uncommon” (Ferric C. Fang & Casadevall, 2011). 
One of Garfield’s intended uses for the citation index was to avoid the uncritical 
citation of wrongful data, by letting the criticism of earlier papers be made available 
(Garfield, 2006a). Relevant papers across disciplines would be made available, where before 
it had been limited to one scientific area by only using subject or keywords (Yancey, 2005). 
This citing across fields may be a reason for the citing of retracted articles, since people who 
are not in the field, might not be aware of the research-scandals in a field. When Bornemann-
Cimenti et al. researched the retractions of Reuben’s, they found that the percentage of 
citations that cited from Reuben’s field, varied between 36% to 60% in the years after 
retraction (Bornemann-Cimenti et al., 2015).  
Bavelas talked about one motive for citing as the act of demonstrating your knowledge 
of the field (Bavelas, 1978). By citing articles that have been retracted what you are really 
doing is demonstrating your lack of knowledge of the field. She also points out that 
sometimes this can lead to the citing of articles that one has not even read (Bavelas, 1978). 
Simkin and Roychowdhury used stochastic methods to determine that as many as 70-90% of 
scientific citations were copied from other reference list (Simkin & Roychowdhury, 2005).  If 
that is a common practice, than the citation of a retracted article is not an impossibility. If you 
combine this with Bavelas expectation that some people use sources that they have not read 
because it is expected of you, this could be a reason for the citation of retracted articles. 
However what Bavelas suggests are sources who have been established as so important to the 
field, be it from arbitrary rules, which means that this process requires some knowledge of the 
field (Bavelas, 1978). This knowledge should be extensive enough to weed out articles that 
are retracted, especially from something as publicised as the Sudbø-case was. Copying a 
reference is not the same as not reading it either. The problem of, in terms of retracted work, 
copying a reference only comes if that means that you do not take the time to read the original 





5.2  HOW CAN WE STOP IT? 
Throughout the literature there have been a clear agreement that even though we are 
experiencing an increase in retractions, not nearly enough articles are being retracted. In the 
last few years articles retracted for research fraud have 
increased nearly tenfold (F. C. Fang et al., 2012). Some 
blame the increased pressure to publish for the increase of 
misconduct. The focus on the impact factor is seen as a 
negative thing by some, and is believed to be one of the 
underlying causes for the increase in misconduct, since so 
much rely upon it. Today the higher ranking journals 
advertise their impact factor in order to encourage people 
to publish in them. Jon Sudbø published in amongst 
others the New England Journals of Medicine and the 
Lancet, both high ranking journals. Yet his published 
articles were wrong.  
Bornemann-Cimenti et al. bring up the reviewing process, 
and the expectation put upon them to catch mistakes, such 
as the citation of a retracted article. With the NEJM 
article, one could expect it since people found errors with 
the article already back in 2001, so one could certainly 
question the peer-reviewing process. With the Lancet article, it was rushed, and the peer-
reviewers were not heard, which means that not only the peer-reviews has a responsibility to 
look for errors, but also the editors. Reviewers and editors may be experienced researcher, yet 
they are not immune to making the same mistakes, or in this case, not catching the same 
mistakes that authors were unable to catch (Bornemann-Cimenti et al., 2015). 
 Fang and Casadevall suggest that there is a correlation between a high impact factor 
and a high retraction rate (Ferric C. Fang & Casadevall, 2011). Which serves as a reason to 
question the impact factor as a measure of quality. This focus on impact factor caused several 
Brazilian journals to do organized citation stacking in order to inflate their journals impact 
factors. They were eventually caught and blamed the focus on the impact factor for their 
“The Lancet has an Impact Factor 
of 45·217. The journal is 
currently ranked second out of 
150 journals in the general 
medicine category”  
(Lancet, 2016) 
“The most recent (2014) impact 
factor for NEJM is 55.873, the 







actions. (Noorden, 2013) The pressure to publish in higher ranking journals was an excuse 
Sudbø also used for his misconduct, claiming that it was his strive for academic greatness that 
caused him to do it.  
The focus on bibliometrics and the use of citation counting have been debated over the 
years, some are eagerly for it, like Garfield, whilst others are against. Citation counting and 
the impact factor might not be the right tool to evaluate scientist, but in terms of the citing of 
retracted articles it is a good tool to better understand the phenomenon, mostly because it 
shines a spotlight on the fact that articles that are retracted are still cited. It provides a clearer 
understanding of the citation of retracted articles, which is important in order to devise ways 
to stop the citing. What has stood out to me as the best ways to do so is to increase the 
visibility of retractions. It is important to make people aware of them. Visibility might be one 
of the reasons to why higher ranking journals have a higher retraction rate, because they are 
put under a higher level of scrutiny, which might mean that misconduct is easier to spot 
(Ferric C. Fang & Casadevall, 2011). Retractions should be easily spotted to, which puts a 
heavy responsibility on the databases to make it clear if and why an article is retracted. As we 
have seen with the Sudbø-case, such a well-publicised case, some of the databases failed to 
make it abundantly clear that the articles were retracted. Another point is the development of 
automated processes which can check this for us. Such a computer program does not exist 
yet. Therefore the responsibility falls on us, to maintain constant vigilance. Blogs such as 
Retraction Watch, is an asset, because it makes people aware of scientific retractions across 
fields. 
5.2.1 WHERE IS SUDBØ NOW? 
Sudbø as a case exemplified well that retracted articles are cited. The level of misconduct that 
he showed, would make you think that he would not be. Yet his findings lives on through the 
wrongfull citations of his retracted articles. 
And as for Sudbø himself? Today he is working as a dentist, banned from doing 
research. Yet he still manages to stir up controversy and strong feeling in others to this day. 
Just recently his image could be found in the pages of the Norwegian newspaper Aftenposten. 
They could report that he has been hired as leader of the clinic at Tannhelsetjenestens 





hiring of Sudbø to be so problematic that they are considering not sending their students there 
for training. The centre has emphasised to the Norwegian Institute of Public Health and to 
Nordic Institute of Dental Materials that Sudbø will in no way be involved in doing research, 
be it the collection of data or in application processes. According to the director of the Oral 
Care Centre, Hilde Vogt Toven, Jon Sudbø was hired, simply because he was the best 
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